GemPharmatech at the 2nd Obesity & Weight Loss Drug Development Summit Europe 2026 📍 Munich, Germany 📅 Oct 28–29, 2026 Don't miss our poster presentation: "GLP-1R Agonism Plus GIPR Antagonism Enhance Weight and Fat Loss in Humanized Mice" See you in Munich! #ObesityResearch

Day 3 at the 80th Anniversary International Conference of the Pharmaceutical Society of Korea! Our team is on site to discuss how #GemPharmatech’s genetically engineered #mousemodels and integrated #preclinical solutions can support target validation and therapeutic development.

GemPharmatech is attending #Neuroscience2026 (SfN)! 📍 Washington, D.C. 📅 Nov 15–18, 2026 📌 Booth #1124 Explore how our #mousemodels can support #neuroscience research — including studies of #Alzheimer's disease, #Parkinson's disease, and other #neurological disorders. #SfN

Meet GemPharmatech at #ACRConvergence2026! 📍 Orlando, Florida 📅 Nov 6–11, 2026 Connect with us to discuss #preclinical research in #autoimmune disease, we will present three posters highlighting preclinical models for #lupus and #ANCA-associated vasculitis. #ACR

How do #preclinical model strategies differ when developing T-cell engagers (#TCEs) for #oncology versus #autoimmunedisease? Join our upcoming webinar: "Preclinical Model Strategies for T-Cell Engagers" 📅 Oct 27, 2026 | 11:00 AM ET 👉 Register now: buff.ly/GSMMFZn #TCE

How do you select the right #preclinical model for systemic lupus erythematosus (#SLE) drug development? In our latest blog, we explore 7 SLE models, covering their mechanisms, disease phenotypes, and applications. 🔗 Read the full blog: buff.ly/N4BbslM #Autoimmune

Thank you for joining us at SoCal Biotech Social last Thursday! 🎉 It was a pleasure connecting with fellow industry professionals, exchanging perspectives, and strengthening relationships across the #biotechcommunity. We look forward to more opportunities to connect! #SanDiego

🍻 Hi, Boston #biotech community! We're inviting you to join us for a casual get-together — "Brews & Biotech: Boston Fall Mixer" at Trillium Fenway. 📆 Oct 28, 2026 ⏰ 4:30 – 7:30 PM EDT 📌 Trillium – Fenway, 401 Park Dr, Boston, MA Register now: buff.ly/voCxF5H

GemPharmatech will be attending BIOPLUS-INTERPHEX KOREA (BIX) 2026 in Seoul, South Korea. 📅 October 28–30, 2026 📍 COEX, Seoul, South Korea We look forward to connecting with colleagues across the biopharmaceutical community. #BIX2026 #PreclinicalResearch #DrugDiscovery

GemPharmatech is heading to Boston for the 2nd Annual T-Cell Engager for Autoimmune Disease Summit! Join Dr. Jun Wang as he presents strategies for evaluating TCE pharmacology and therapeutic efficacy using complementary #preclinical models. 📅 Oct 28 | 11:30 AM–12:00 PM #TCE

We’re at the 50th #KSNS Autumn Workshop in Pyeongchang! 📍 Visit us at Booth #59 Our team is here to discuss how our genetically engineered and humanized #animalmodels, in vivo #efficacystudies, and integrated #preclinical solutions can support your research. #KSNS2026

Highlights from our visit to Leibniz-HKI in Jena, Germany! Dr. Xiang Gao, Chairman of GemPharmatech, presented “From Models to Discovery,” exploring how innovative mouse models bridge basic research and #preclinical drug development. Read more: buff.ly/W08p05c #Seminar

🧬 Final Day at #FestivalofBiologics Basel 2026! Stop by GemPharmatech at Booth #188 before the event wraps up today. Explore how our genetically engineered and humanized mouse models and integrated preclinical solutions can support your biologics development programs. #FOB2026

GemPharmatech is attending #APLAR2026 in Seoul, Korea! Join our poster presentation: [𝟭𝟳𝟲𝟵] "Application of a Human Immune System-Reconstituted Mouse Model of Lupus in Evaluating the Efficacy of B Cell-Targeting Therapies" 🕚️ Nov 1, 2026, 10:50–11:15 a.m. KST #APLAR

GemPharmatech is attending the 2026 80th Anniversary International Conference of the Pharmaceutical Society of Korea! Connect with us to discuss your #preclinical research needs and explore how our model resources can support #pharmaceutical innovation. #GemPharmatech #biotech

What should #preclinical studies address when developing T-cell engagers (#TCEs) across different therapeutic contexts? Join our webinar, "Preclinical Model Strategies for TCEs: From Oncology to Autoimmune Disease," to learn more. 👉 Register now: buff.ly/i0idyeB

Thank you to everyone who joined our seminar, “Genetically Modified Mouse Models and Applications,” last week at Campus Neuherberg! It was a great opportunity to connect with the local scientific community, exchange ideas, and learn more about researchers’ needs. #GemPharmatech

GemPharmatech is proud to sponsor the 2nd Annual T-Cell Engager for #AutoimmuneDisease Summit! 📅 October 27–29, 2026 📍 Boston, MA Join us to discover how GemPharmatech’s advanced #mousemodels and #preclinical research solutions support your #TCE programs. #TCellEngager

This month, GemPharmatech is expanding its #mousemodel portfolio with new strains across key research areas, supporting diverse needs in #preclinical research and #drugdevelopment. 🔎 Explore October’s new models and search our full catalog: buff.ly/0LX8rpg #animalmodel

Thank you to everyone who connected with #GemPharmatech at EgeSAM Republic Symposiums IV in İzmir, Türkiye, last week! We appreciate the opportunity to engage with the local #biotech and scientific community in Türkiye and exchange perspectives on #preclinical model strategies.